Overview

FREEDOM - First Real-Life Evaluation of Enablex Done in ZA Overactive Bladder Patients During a 3 Months Period

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
Patient perspective on Overactive Bladder and symptoms experienced after administration of Darifenacin
Details
Lead Sponsor:
Bayer
Treatments:
Darifenacin